Studies have shown that cytotoxic CD8+ T cells are important effector cells that contribute to adaptive immunity by specifically recognizing and wiping out tumor cells, and they are thereby associated with improved survival in cancer patients20,72. This evidence concerns the gene CD8A and neoplasm.